The present invention relates to the use of 8-iso prostaglandins and their
derivatives for decreasing intraocular pressure, for example in the
treatment of glaucoma It is based, at least in part, on the discovery
that 8-iso prostaglandin E.sub.2 effectively decreased intraocular
pressure by a trabecular meshwork outflow mechanism.